BRIEF published on 10/03/2025 at 18:14, 8 months 22 days ago Edenred Extends Share Buyback Program Edenred Share Buyback Investment Financial Strategy Stock Cancellation
BRIEF published on 10/03/2025 at 18:14, 8 months 22 days ago EDENRED Renforce son Programme de Rachat d'Actions Edenred Marché Financier Rachat D'actions Capital Social Programme D'investissement
REGULATED PRESS RELEASE published on 10/03/2025 at 18:09, 8 months 22 days ago Share buyback mandate Edenred extends share buyback operation with new mandate from Oct 3, 2025, for initial €25 million, aiming at €225 million till Nov 30, 2027. 10.6M shares bought for €375M as of Oct 3 Edenred Share Buyback Digital Platform Investment Services Provider Corporate Clients
REGULATED PRESS RELEASE published on 10/03/2025 at 18:09, 8 months 22 days ago Mandat de rachat d’actions Edenred annonce un nouveau mandat de rachat d'actions pour un montant initial de 25 millions d'euros, avec intention de le prolonger jusqu'en novembre 2027 Edenred Investissement OPA Rachat D'actions Mandat
BRIEF published on 10/03/2025 at 14:18, 8 months 23 days ago Nombre d'actions et droits de vote d'Edenred au 30 septembre 2025 Edenred Droits De Vote Actions Investisseurs 2025
BRIEF published on 10/03/2025 at 14:18, 8 months 23 days ago Edenred Releases Share Capital and Voting Rights Update Edenred Share Capital Voting Rights Financial Report September 2025
REGULATED PRESS RELEASE published on 10/03/2025 at 14:13, 8 months 23 days ago Disclosure of Share Capital and Voting Rights as of September 30, 2025 Edenred discloses share capital and voting rights as of September 30, 2025, in accordance with regulatory requirements Edenred Share Capital Voting Rights Disclosure Regulatory Requirements
REGULATED PRESS RELEASE published on 10/03/2025 at 14:13, 8 months 23 days ago Déclaration du nombre d’actions et droits de vote au 30 septembre 2025 Edenred déclare le nombre d'actions et de droits de vote conformément aux réglementations financières en vigueur Edenred Déclaration Droits De Vote Réglementation Financière Actions
BRIEF published on 09/16/2025 at 08:42, 9 months 10 days ago Kelly Richdale rejoint le Conseil d'administration d'Edenred Edenred Conseil D'administration Technologies De Pointe Cooptation Kelly Richdale
BRIEF published on 09/16/2025 at 08:42, 9 months 10 days ago Kelly Richdale Joins Edenred's Board of Directors Edenred Independent Director Board Appointment Kelly Richdale Technology Expert
Published on 06/26/2026 at 14:05, 3 hours 31 minutes ago SouthGobi Announces Voting Results of Annual General Meeting of Shareholders
Published on 06/26/2026 at 14:00, 3 hours 36 minutes ago Dateline Chairman Invests $1.95 million through Options Exercise
Published on 06/26/2026 at 13:00, 4 hours 36 minutes ago Aclara Secures Tax Exemption Approval of Over US$20 Million For Its U.S. Heavy Rare Earth Separation Facility in Louisiana
Published on 06/26/2026 at 12:45, 4 hours 51 minutes ago Northern Dynasty Reports Oral Arguments Held
Published on 06/26/2026 at 17:05, 31 minutes ago NAKIKI SE Receives an Adverse Opinion on Its 2024 Financial Statements and Management Report
Published on 06/26/2026 at 17:00, 36 minutes ago Darwin AG Announces Results of the 2026 Annual General Meeting
Published on 06/26/2026 at 15:30, 2 hours 6 minutes ago JMGO Extends Special Savings Beyond Prime Day with N3 Ultimate at Its Best Price Since Launch
Published on 06/26/2026 at 15:23, 2 hours 13 minutes ago Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
Published on 06/26/2026 at 07:00, 10 hours 36 minutes ago Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/26/2026 at 07:00, 10 hours 36 minutes ago Améliorer la santé des femmes grâce au diagnostic rapide : bioMérieux dépose auprès de la FDA une demande combinée d’autorisation 510(k) et de dérogation CLIA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel
